Clorox Co (CLX) Stock Price Today
Aura AI Summary
Key Stats
- $10.45BMarket Cap
- 1,974,144Volume
- Consumer StaplesSector
- $127.1652W High
- $80.4152W Low
- 96 DaysTypical Hold Time
- $15.83BEnterprise Value
- 5.79%Div Yield
- 0% Sell | 100% BuyTrading Activity
Track Clorox Co (CLX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Clorox Co has traded between a low of $80.41 and a high of $127.16, highlighting its annual price range. Buy and sell Clorox Co shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Clorox Co
With a history dating back more than 100 years, Clorox now plays in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just shy of 85% of Clorox's sales stem from its home turf.
Most Recent News
XBiotech appoints Sushma Shivaswamy and Jan-Paul Simard as co-CEOs to lead antibody therapy development.
XBiotech Inc. announced the appointment of Sushma Shivaswamy and Jan-Paul Simard as co-chief executive officers, effective October 23, 2026. Shivaswamy, with 17 years at the company, has led scientific operations and was interim CEO since December 20...

XBiotech appoints Jan-Paul Simard as Co-CEO alongside Sushma Shivaswamy to strengthen leadership.
XBiotech Inc. announced the election of Jan-Paul Simard as Co-Chief Executive Officer alongside current CEO Dr. Sushma Shivaswamy, effective October 23, 2026. This leadership change aims to leverage their complementary skills and scientific expertise...

Heineken warns weight-loss drugs like Ozempic may reduce beer drinking, urging pubs to adapt or lose revenue.
Heineken has privately warned British pubs that the rise of GLP-1 weight-loss drugs such as Ozempic and Wegovy could reduce customers' desire to drink alcohol, especially multi-pint rounds, which are key to pub revenue. The company suggests promoting...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.